Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$11.8B
198M shares
52-week range
$22.16 – $73.75
77% from low
Sector
SERVICES-HOME HEALTH CARE SERVICES
Exchange
NASDAQ
CS
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services, and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
www.brightspringhealth.comNo one on the platform currently holds BTSG.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-06-30 | 372,700 | $8.8M |
No one on the platform has traded BTSG yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$BTSG wtf. That a big drop out of no where with no news. Don't like it.
View on StockTwits ↗$BTSG do they have any exposure to changes to Part D (drug plan) Medicare pricing?
View on StockTwits ↗$BTSG Buy Deutsche Bank raises target price to $70 from $60 Leerink Partners raises target to $72 from $49 Raymond James cuts target to $75 from $80
View on StockTwits ↗$BTSG “it’s only up 1000% in nearly a straight line why down”
View on StockTwits ↗$BTSG looks like a strong buy-the-dip candidate after earnings. The company beat expectations, raised guidance, and continues to grow revenue, EBITDA, and cash flow. The stock is selling off mainly because expectations were high and traders are taking profits. Fundamentals improved while the share price dropped. I’m adding gradually, not chasing all at once.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $15.3B | +20.1% | $1.80 | $1.72–$1.85 | 34.3× | 9 |
| 2027 | $17.4B | +13.5% | $2.28 | $2.17–$2.49 | 27.1× | 9 |
| 2028 | $19.9B | +14.4% | $2.79 | $2.30–$3.39 | 22.1× | 5 |
| 2029 | $24.5B | +23.4% | $3.82 | $3.71–$4.00 | 16.2× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-31 | $0.40 | $0.45 | +13.6% |
| 2026-05-01 | $0.29 | $0.39 | +34.5% |
| 2026-02-27 | $0.34 | $0.33 | -2.9% |
| 2025-10-31 | $0.26 | $0.30 | +13.9% |
| 2025-08-01 | $0.19 | $0.22 | +15.8% |
| 2025-05-02 | $0.08 | $0.19 | +137.5% |
| 2025-03-06 | $0.19 | $0.22 | +15.8% |
| 2024-11-01 | $0.18 |
| $0.11 |
| -38.9% |
| $8.8B |
| — |
| IRTCiRhythm Technologies, Inc. | $126.44 | +2.66% | $4.2B | — |
| KRYSKrystal Biotech, Inc. | $332.27 | +1.20% | $9.8B | — |
Source: Financial Modeling Prep · peers by sector/industry